Banced Corp boosted its position in AmerisourceBergen Corp. (NYSE:ABC) by 2.3% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 5,468 shares of the company’s stock after buying an additional 122 shares during the period. Banced Corp’s holdings in AmerisourceBergen Corp. were worth $567,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of ABC. Reynolds Capital Management boosted its stake in AmerisourceBergen Corp. by 21.4% in the fourth quarter. Reynolds Capital Management now owns 3,400 shares of the company’s stock worth $353,000 after buying an additional 600 shares during the period. ICON Advisers boosted its stake in AmerisourceBergen Corp. by 61.6% in the third quarter. ICON Advisers now owns 69,500 shares of the company’s stock worth $6,602,000 after buying an additional 26,500 shares during the period. West Oak Capital boosted its stake in AmerisourceBergen Corp. by 5.5% in the fourth quarter. West Oak Capital now owns 20,210 shares of the company’s stock worth $2,095,979 after buying an additional 1,050 shares during the period. Hollencrest Securities boosted its stake in AmerisourceBergen Corp. by 4.9% in the fourth quarter. Hollencrest Securities now owns 4,980 shares of the company’s stock worth $516,000 after buying an additional 232 shares during the period. Finally, Janus Capital Management boosted its stake in AmerisourceBergen Corp. by 1.8% in the third quarter. Janus Capital Management now owns 4,524,266 shares of the company’s stock worth $429,760,000 after buying an additional 78,465 shares during the period.

Shares of AmerisourceBergen Corp. (NYSE:ABC) traded up 0.47% during midday trading on Friday, hitting $91.00. The stock had a trading volume of 1,985,773 shares. The company’s market cap is $18.71 billion. AmerisourceBergen Corp. has a one year low of $89.68 and a one year high of $120.68. The firm has a 50 day moving average of $99.49 and a 200-day moving average of $100.81.

AmerisourceBergen Corp. (NYSE:ABC) last issued its earnings results on Thursday, October 29th. The company reported $1.17 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.18 by $0.01. During the same quarter in the prior year, the company earned $1.10 earnings per share. The business had revenue of $35.50 billion for the quarter, compared to analysts’ expectations of $34.62 billion. The firm’s revenue was up 12.3% compared to the same quarter last year. On average, analysts forecast that AmerisourceBergen Corp. will post $5.83 earnings per share for the current fiscal year.

Several equities analysts recently issued reports on the company. Zacks Investment Research cut AmerisourceBergen Corp. from a “buy” rating to a “hold” rating in a research report on Thursday, January 14th. Robert W. Baird restated a “neutral” rating and issued a $108.00 price target (down previously from $113.00) on shares of AmerisourceBergen Corp. in a research report on Tuesday, January 12th. Raymond James cut AmerisourceBergen Corp. from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 6th. Mizuho dropped their price target on AmerisourceBergen Corp. from $112.00 to $105.00 and set a “neutral” rating on the stock in a research report on Wednesday, November 18th. Finally, Credit Suisse assumed coverage on AmerisourceBergen Corp. in a research report on Tuesday, November 17th. They issued an “outperform” rating and a $121.00 price target on the stock. Eleven equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. AmerisourceBergen Corp. has an average rating of “Hold” and a consensus price target of $107.77.

In other AmerisourceBergen Corp. news, EVP Dale Danilewitz sold 6,388 shares of the firm’s stock in a transaction that occurred on Monday, November 16th. The shares were sold at an average price of $96.86, for a total value of $618,741.68. Following the sale, the executive vice president now owns 3,956 shares in the company, valued at $383,178.16. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Steven H. Collis sold 27,148 shares of the firm’s stock in a transaction that occurred on Monday, December 21st. The shares were sold at an average price of $102.23, for a total transaction of $2,775,340.04. Following the completion of the sale, the chief executive officer now owns 252,204 shares in the company, valued at approximately $25,782,814.92. The disclosure for this sale can be found here.

AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company operates through two segments: Pharmaceutical Distribution and Other. The Company also provides data and other services to its manufacturing customers. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. The Company provides pharmacy services to certain specialty drug patients. Additionally, the Company offers healthcare providers and pharmaceutical manufacturers with services, including reimbursement and pharmaceutical consulting services, logistics services, inventory management, pharmacy automation and pharmacy management. The Company has a distribution facility network totaling approximately 30 distribution facilities in the United States.

12 Month Chart for NYSE:ABC

Receive News & Ratings for AmerisourceBergen Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen Corp. and related companies with MarketBeat.com's FREE daily email newsletter.